US Patent 10138221 Salts of nilotinib and polymorphs thereof
Patent 10138221 was granted and assigned to Sun Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10138221 Salts of nilotinib and polymorphs thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
